Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative

医学 楔形切除术 腺癌 肺癌 外科 内科学 癌症 切除术
作者
Di Li,Chaoqiang Deng,Shengping Wang,Yuan Li,Yang Zhang,Haiquan Chen
出处
期刊:The Journal of Thoracic and Cardiovascular Surgery [Elsevier BV]
卷期号:164 (6): 1614-1622.e1 被引量:17
标识
DOI:10.1016/j.jtcvs.2022.06.017
摘要

Objective This study aimed to reveal the long-term outcomes of patients with lung cancer with adenocarcinoma in situ or minimally invasive adenocarcinoma after resection, in the context of the different surgical resection types. Methods Patients with lung adenocarcinoma who underwent resection between December 2007 and December 2012 were reviewed. Patients with pathological adenocarcinoma in situ or minimally invasive adenocarcinoma were enrolled. Postoperative survival and risk of developing second primary lung cancer were analyzed. Results After reevaluating the histological findings of 1696 patients with lung adenocarcinoma, we enrolled 53 with adenocarcinoma in situ and 72 with minimally invasive adenocarcinoma for analyses. Of all 125 patients with adenocarcinoma in situ/minimally invasive adenocarcinoma, 86 (68.8%) were female, 114 (91.2%) were nonsmokers, and most of them (78, 62.4%) underwent wedge resection. The median follow-up period after surgery was 111 months. The 10-year recurrence-free survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were all 100%, and the 10-year overall survivals of adenocarcinoma in situ and minimally invasive adenocarcinoma were 98.1% and 97.2%, respectively. There was no difference in 10-year recurrence-free survival between patients who underwent lobectomy and wedge resection. EGFR mutations were detected in 63.1% (41/65) of patients who underwent mutational analysis. The risks of developing second primary lung cancer for adenocarcinoma in situ and minimally invasive adenocarcinoma 10 years after resection were 8.4% and 4.3% (P = .298), respectively, and were not correlated with EGFR mutation status (P = .525). Conclusions Pathological adenocarcinoma in situ and minimally invasive adenocarcinoma have no recurrence during 10-year follow-up after resection, regardless of surgical procedure types. Surgery is curative for these patients, and wedge resection is the preferred surgical procedure for nodules in the proper location.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
过眼云烟发布了新的文献求助30
刚刚
1秒前
2秒前
5秒前
5秒前
Yang发布了新的文献求助10
7秒前
xcky0917发布了新的文献求助10
7秒前
iamhieuxk发布了新的文献求助10
8秒前
清新的苑博完成签到,获得积分10
9秒前
过眼云烟完成签到,获得积分10
11秒前
huahua完成签到 ,获得积分10
11秒前
xcky0917完成签到,获得积分10
12秒前
心碎的黄焖鸡完成签到 ,获得积分10
15秒前
15秒前
Ryan完成签到,获得积分10
16秒前
文都哲发布了新的文献求助10
19秒前
19秒前
英俊的铭应助晨曦采纳,获得10
19秒前
快乐冰之完成签到 ,获得积分10
21秒前
午见千山应助执执采纳,获得10
23秒前
傲娇诗发布了新的文献求助30
26秒前
tsntn完成签到,获得积分10
26秒前
万能图书馆应助zml采纳,获得10
27秒前
成就的南霜完成签到,获得积分10
28秒前
28秒前
30秒前
辛辛完成签到,获得积分10
31秒前
lalala完成签到,获得积分10
32秒前
既白完成签到 ,获得积分10
34秒前
CodeCraft应助辛辛采纳,获得100
34秒前
小样发布了新的文献求助10
35秒前
善良高山发布了新的文献求助10
35秒前
小齐完成签到 ,获得积分10
36秒前
hw发布了新的文献求助10
37秒前
小鱼完成签到 ,获得积分10
43秒前
xff完成签到,获得积分10
44秒前
虚幻的赛君完成签到,获得积分10
46秒前
科研通AI5应助傲娇诗采纳,获得10
46秒前
执执完成签到,获得积分10
47秒前
kate完成签到,获得积分10
49秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
Technologies supporting mass customization of apparel: A pilot project 450
Mixing the elements of mass customisation 360
Периодизация спортивной тренировки. Общая теория и её практическое применение 310
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
Nucleophilic substitution in azasydnone-modified dinitroanisoles 300
Political Ideologies Their Origins and Impact 13th Edition 260
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3781475
求助须知:如何正确求助?哪些是违规求助? 3327071
关于积分的说明 10229393
捐赠科研通 3041969
什么是DOI,文献DOI怎么找? 1669742
邀请新用户注册赠送积分活动 799258
科研通“疑难数据库(出版商)”最低求助积分说明 758757